Results 111 to 120 of about 4,789,466 (273)

Path‐Decoupled Cation‐Eutaxy III–V van der Waals Memristive Semiconductors for Mitigating the Neuromorphic Accuracy‐Energy Trade‐off

open access: yesAdvanced Materials, EarlyView.
Path‐decoupled III–V van der Waals memtransistors spatially separate ionic and electronic transport to overcome the conventional trade‐off between accuracy and energy in neuromorphic hardware. Mobile K+ ions in the vdW gaps set a wide conductance window, Gmax/Gmin, while gate‐tunable hole conduction lowers programming energy, enabling reliable ...
Jihong Bae   +13 more
wiley   +1 more source

Hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitors versus lenvatinib plus PD-1 inhibitors as first-line treatment for hepatocellular carcinoma with high tumour burden and portal vein tumour thrombus (CHANCE 2416): study protocol of a multicentre, retrospective, target trial emulation design

open access: yesBMJ Open
Background Advanced-stage hepatocellular carcinoma (HCC) with high tumour burden and portal vein tumour thrombus (PVTT) is usually associated with poor survival outcomes.
Jiaxi Liu, Songnan Zhang, Haibo Shao
doaj   +1 more source

Phase Engineering of Nanomaterials (PEN): Evolution, Current Challenges, and Future Opportunities

open access: yesAdvanced Materials, EarlyView.
This review summarizes the synthesis, phase transition, advanced characterization spanning ex situ to in situ and operando techniques, and diverse applications of phase engineering of nanomaterials (PEN). It further outlines key challenges and future opportunities, such as phase stability, architecture control, and artificial intelligence (AI)‐driven ...
Ye Chen   +7 more
wiley   +1 more source

Empagliflozin vs Dapagliflozin in Heart Failure: a Target Trial Emulation

open access: yesJournal of Cardiac Failure
No randomized trial has compared head-to-head the effects of empagliflozin and dapagliflozin in patients with heart failure.This nationwide, prospective, new-user, active-comparator cohort study emulated a pragmatic target trial comparing heart failure rehospitalization and all-cause death risks in adults with heart failure initiating empagliflozin vs.
KASPER BONNESEN   +4 more
openaire   +3 more sources

Radiative Thermal Management for Extreme Environments: Mechanisms and Design Strategies

open access: yesAdvanced Materials, EarlyView.
In this review, we discuss the fundamental mechanisms of radiative cooling and solar heating, material and structural design strategies, hybrid approaches integrating additional heat transfer pathways, and durability‐oriented designs addressing environmental stresses.
Hyung Rae Kim   +5 more
wiley   +1 more source

Intimate partner relationship strain and general health for prospective mothers and their child: A target trial emulation study.

open access: yes
Intimate partner relationship strain and general health for prospective mothers and their child: A target trial emulation ...
Allison K Farrell (13345866)   +8 more
core  

Comparative effectiveness on all-cause mortality for treatment with GLP1ra, SGLT2i and DPP-IVi in comorbid schizophrenia and type 2 diabetes: A Danish nationwide target-trial emulation study

open access: yes
Comparative effectiveness on all-cause mortality for treatment with GLP1ra, SGLT2i and DPP-IVi in comorbid schizophrenia and type 2 diabetes: A Danish nationwide target-trial emulation ...
Ole Köhler-Forsberg   +3 more
core   +2 more sources

Advances in Bio‐Integrated Edge Computing Systems for Smart and Connected Health

open access: yesAdvanced Materials, EarlyView.
This review explores advances in bio‐integrated edge computing for healthcare, focusing on co‐designing computing, sensing, and energy strategies to overcome integration and power challenges for optimized, decentralized operation. ABSTRACT Recent advances in bio‐integrated healthcare technologies have enabled continuous, high‐resolution monitoring and ...
Gyuwon Kim   +4 more
wiley   +1 more source

Trial emulation in nephrology

open access: yes
Background Patients with kidney disease and failure have often been excluded from randomized trials leaving practitioners with limited data to navigate their decision-making at critical stages of patient’s lives.
Jule Pinter
core   +1 more source

Home - About - Disclaimer - Privacy